CorMedix Inc (NASDAQ:CRMD) has a beta value of 1.61 and has seen 2.26 million shares traded in the recent trading session. The company, currently valued at $1.16B, closed the recent trade at $2049999.9999999998 per share which meant it gained $2049986.39 on the day or 2262284% during that session. The CRMD stock price is 100.0% off its 52-week high price of $15.38 and 100.0% above the 52-week low of $3.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.71 million shares traded. The 3-month trading volume is 2.05 million shares.
The consensus among analysts is that CorMedix Inc (CRMD) is Buy stock at the moment, with a recommendation rating of 1.00. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.12.
CorMedix Inc (NASDAQ:CRMD) trade information
Over the past 30 days, the shares of CorMedix Inc (NASDAQ:CRMD) have changed 38.72%. Short interest in the company has seen 8.53 million shares shorted with days to cover at 4.03.
Wall Street analysts have a consensus price target for the stock at $9, which means that the shares’ value could drop -22777677.78% from the levels at last check today.. The projected low price target is $9.0 while the price target rests at a high of $9.0. In that case, then, we find that the latest price level in today’s session is 100.0% off the targeted high while a plunge would see the stock lose 100.0% from the levels at last check today..
CorMedix Inc (CRMD) estimates and forecasts
The company’s shares have gained 99.63% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 233.23%.
6 analysts offering their estimates for the company have set an average revenue estimate of 30M for the current quarter. 6 have an estimated revenue figure of 35.74M for the next ending quarter. Year-ago sales stood 806.12k and 11.46M respectively for this quarter and the next, and analysts expect sales will grow by 3,621.55% for the current quarter and 233.23% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 29.80% over the past 5 years.
CRMD Dividends
CorMedix Inc is expected to release its next earnings report on 2025-May-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
Insiders own 1.19% of the company shares, while shares held by institutions stand at 37.17% with a share float percentage of 37.61%. Investors are also buoyed by the number of investors in a company, with CorMedix Inc having a total of 185.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 3.55 million shares worth more than $15.39 million. As of 2024-06-30, BLACKROCK INC. held 6.167% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 2.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $12.57 million and represent 5.0373% of shares outstanding.
